Skip to content
TechCrunch·

🔬Musely Secures $360M for Prescription Skincare Growth

How Musely is Growing Without Burning Cash

TL;DR

Musely, a prescription skincare company, has secured over $360 million in non-dilutive capital from CVF. This funding will support customer growth and marketing efforts without raising equity since 2014.

Musely has raised over $360 million in non-dilutive capital to fuel its prescription skincare business, marking a rare feat of sustained growth with minimal equity dilution. The company, which pivoted from wellness to skincare in 2019, is now cash flow positive and growing at an impressive 50% year-over-year rate. With CVF's investment, Musely can expand its customer base without the usual DTC brand capital burn.

Musely Secures $360M for Prescription Skincare Growth — TechCrunch

Key Points

1

Musely has secured over $360 million in non-dilutive funding from the Consumer Ventures Fund (CVF).

2

The company specializes in compounded treatments for skin, hair, and menopause care, serving over 1.2 million patients.

3

Since pivoting to prescription skincare in 2019, Musely has grown revenue by an average of 50% year-over-year.

4

Musely's unique model allows it to remain cash flow positive while raising no equity capital since a $20M raise in 2014.

5

CVF funding will support sales and marketing efforts for customer growth, joining portfolio companies like Grammarly and Lemonade.

Why It Matters

If you're running a DTC brand, Musely's model is worth studying. They've grown revenue by 50% YoY without raising equity since 2014, proving that non-dilutive capital can fuel growth efficiently. This approach could be a game-changer for brands looking to avoid the high costs of customer acquisition.

non-dilutive fundingprescription skincarecustomer growthDTC brand

Frequently Asked Questions

Why does this matter?

If you're running a DTC brand, Musely's model is worth studying. They've grown revenue by 50% YoY without raising equity since 2014, proving that non-dilutive capital can fuel growth efficiently. This approach could be a game-changer for brands looking to avoid the high costs of customer acquisition.

What happened?

Musely, a prescription skincare company, has secured over $360 million in non-dilutive capital from CVF. This funding will support customer growth and marketing efforts without raising equity since 2014.

Comments

Subscribe to join the conversation...

Be the first to comment

Enjoyed this article?

Get it daily. 7am. Free. Reads in 5 minutes.

Join 3,313 builders reading daily.

Also get